Aptevo Therapeutics Inc.

NASDAQ: APVO · Real-Time Price · USD
1.99
-0.05 (-2.45%)
At close: Aug 15, 2025, 3:05 PM

Aptevo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
8.71M 16.9M 22.64M 45.04M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -6.76M 68K
Receivables
n/a n/a 2.5M 3.66M
Inventory
n/a n/a 1.57M 3.08M
Other Current Assets
256K 689K 744K 2.04M
Total Current Assets
10.66M 19.07M 27.45M 52.57M
Property-Plant & Equipment
4.93M 5.78M 6.76M 3.96M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
4.93M 5.78M 6.76M 4.03M
Total Assets
15.59M 24.84M 34.22M 56.6M
Account Payables
3.05M 3.98M 3.5M 3.46M
Deferred Revenue
n/a n/a -3.5M -3.46M
Short-Term Debt
n/a n/a 2M 11.67M
Other Current Liabilities
3.15M 1.14M 1.1M 17.55M
Total Current Liabilities
6.21M 7.22M 8.71M 34.76M
Long-Term Debt
n/a n/a 1.46M 3.71M
Other Long-Term Liabilities
n/a n/a n/a 15.58M
Total Long-Term Liabilities
4.63M 5.4M 7.54M 20.63M
Total Liabilities
10.84M 12.62M 16.24M 55.38M
Total Debt
4.63M 5.4M 9.54M 16.71M
Common Stock
84K 61K 48K 47K
Retained Earnings
-247.58M -223.45M -206.04M -214.06M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
4.75M 12.22M 17.97M 1.22M
Total Investments
n/a n/a n/a n/a